Join Our Next Live Briefing!
July 26, 2022 | Noon EDT | EPISODE 39
Precision Wellness: How The Growth in Genetic Knowledge is Accelerating The Movement To Proactive Medicine Health
David Johnson, CEO at 4Sight Health
Key Learnings
- Understand the increase in genetic knowledge, its profound impact on medicine’s ability to predict the advent of chronic diseases earlier and thereby improve therapeutic interventions to prevent or delay disease onset
- Precision wellness will lead to a profound shift in healthcare resource allocation into preventive care that will lengthen healthy life spans
- Over the Rainbow: Healthcare will change more in the next ten years than it has in the last one hundred years
Live Briefings
The Precision Medicine Institute's weekly live briefings feature experts covering today's most timely and critical precision medicine topics that hospital and health system executives need to understand.
Sponsored By
Stay Informed and Ahead of the Curve With Live Briefings That Matter
The Precision Medicine Institute's live briefings are free, weekly, 30-minute webinars that deliver useful, timely, and actionable information on precision medicine to CEOs, COOs, CFOs, CMOs, and other executives within hospitals, health systems, and multispecialty clinics. They feature thought leaders from across the field of precision medicine and are developed and moderated by Anne Tate and Deb Hewitt-Smith of our partner company, Talking Laboratories.
Subscribe to receive weekly invitations to our live briefings, including topic and expert speaker information and other important details.
Anne Tate, MT (ASCP), SC, MBA, MHI has more than 25 years of experience in the laboratory management and healthcare consulting business. She is an experienced professional with a demonstrated history of managing laboratory information. Anne is fueled by her passion for laboratory informatics and software tools that enable the laboratory to achieve operational excellence.
Deb Hewett-Smith is a strategic and innovative leader with proven success in driving results and empowering teams in the highly competitive healthcare IT and medical device industry sectors. With more than 25 years of experience, Deb is effective at building programs that connect the dots between customer value and business growth/retention.
Live Briefing Library
Look for previous episodes? Check out all our past episodes below!
Volume 2
Recorded July 19, 2022 | Episode 38
The Expanding Role of Cancer Genetic Counselors
Betsy Smith, MS, Certified Genetic Counselor, Benefis Sletten Cancer Institute
Recorded July 12, 2022 | Episode 37
Precision Medicine As A Population Health Tactic - Is This A Game Changer For Healthcare?
Howard McLeod, PharmD, Executive Clinical Director, Precision Health, Intermountain Healthcare
Recorded June 21, 2022 | Episode 36
Impact of Potential Retirement of Diagnosis Codes Covering NGS on Patient Testing and Lab Revenue
Jeff Schreier, MBA, Senior Director, DXRX Lab Relations and Dave Smart, PhD, Senior Director, Analytics, Data Team at Diaceutics
Recorded June 7, 2022 | Episode 35
Use of Natural Language Processing (NLP) Analytics to Identify Key Clinical Events to Address Specific Real-World Questions in the Community Oncology Setting
Patricia Goede, PhD, VP, Clinical Informatics and Linh Mekuria, MPA, Senior Clinical Informaticist, XIFIN, Inc
Recorded June 2, 2022 | Episode 34
How Digital Pathology is Fueling Precision Medicine Healthcare Data
Lisa-Jean Clifford, COO and Chief Strategy Officer, Gestalt Diagnostics
Recorded May 24, 2022 | Episode 33
Precision Medicine Regulation: What Is The Current Situation and Where Are We Headed?
Courtney Tito, Partner at Nelson Mullins
Recorded May 17, 2022 | Episode 32
How Labs Can Use PharmDs To Turn Test Results into Actionable Intelligence For Health Plans To Better Identify Eligible Risk Adjustment Patients
Rick VanNess, MS, Director of Product Management, Rhodes Group, Inc.
Recorded May 3, 2022 | Episode 31
The Future of AI in a Millennial World
Ted Schwab, CEO of Artrya Health
Recorded April 19, 2022 | Episode 30
Moving the Needle on Precision Medicine Using Liquid Biopsies: Opportunities and Challenges
Pashtoon M. Kasi, MD, MS, Weill Cornell Medicine and New York-Presbyterian Hospital
Recorded April 12, 2022 | Episode 29
Curating the Genome to Drive Precision Diagnosis in Clinical Care
Mark Kiel, CSO & Co-Founder, Genomenon
Recorded April 5, 2022 | Episode 28
The Clinical Implementation of Precision Health at Intermountain Healthcare: Benefits for Patients and the Community
Lincoln Nadauld, MD, PhD, Vice President and Chief of Precision Health and Academics, Intermountain Healthcare
Recorded Mar. 22, 2022 | Episode 27
Advancing Precision Medicine with RNA Next Generation Sequencing
Maher Albitar, CEO & CMO at Genomic Testing Cooperative
Recorded Mar. 15, 2022 | Episode 26
How Big Data and Diagnostic Technology Evolution Helped us Manage the Pandemic
Paul Mango, former Deputy Chief of Staff, U.S. Department of Health and Human Services
Recorded Mar. 8, 2022 | Episode 25
Artificial Intelligence: Practical Applications of AI in Healthcare and Diagnostics
Ajit Singh, PhD, Managing Director, Artiman Ventures
Recorded Mar. 1, 2022 | Episode 24
Integrated End-to-End Solutions for Hereditary NGS Panel Testing
Jeanette McCarthy, MPH, PhD, Vice President, Fabric Genomics
Recorded Feb. 22, 2022 | Episode 23
Generating Novel Insights Through AI and Multimodal Analysis
Philippe Menu, MD, PhD, MBA and Chief Medical Officer at SOPHiA GENETICS
Recorded Feb. 15, 2022 | Episode 22
How Technology-Enabled Processes Are Personalizing the Patient Experience
John Glaser, Executive in Residence at Harvard Medical School
Recorded Feb. 8, 2022 | Episode 21
Reimbursement and Regulatory Risk in Genetic Testing
Speakers: Michael Arrigo, CEO, No World Borders and Rob Metcalf, CEO, Concert Genetics
Recorded Feb. 1, 2022 | Episode 20
The 2022 Debate on the Statutory Reform of Diagnostic Oversight
Thomas Sparkman, Senior Vice President of Government Affairs and Policy, American Clinical Laboratory Association
![MC headshot small[1]](https://precision-medicine-institute.com/wp-content/uploads/bb-plugin/cache/MC-headshot-small1-150x150-circle.jpeg "MC headshot small[1]")
Recorded Jan. 25, 2022 | Episode 19
Strategies to Ensure Health Plan Coverage of Emerging Diagnostic Technologies
Maude Champagne, Pharmacologist and Healthcare Value Expert, Illumina
Recorded Jan. 18, 2022 | Episode 18
Digital Pathology - A Foundation for Precision Medicine
Lisa-Jean Clifford, COO and Chief Strategy Officer, Gestalt Diagnostics
Recorded Jan. 4, 2022 | Episode 17
Pharmacogenomics Laboratory Stewardship: How Labs Can Leverage PharmDs for Laboratory Test Ordering, Retrieval, Interpretation, and Reimbursement
Becky Winslow, BS, PharmD, Founder of inGENEious RX, LLC Precision Medicine Consultants
Volume 1
Recorded December 14, 2021 | Episode 16
Medical Necessity Apocalypse: Aligning patients, laboratories and payers to prevent financial toxicity and improve reimbursement
Michael Astion, MD, Medical Director and Jessie Conta, genetic counselor and Laboratory Stewardship Program Manager, Department of Laboratories, Seattle Children’s Hospital
Recorded December 7, 2021 | Episode 15
Developing a Strategy for Next Generation Sequencing Reimbursement - Understanding the Barriers and Path to Consistent Revenue Growth
Robert Dumanois, Director of Reimbursement Strategy, Clinical Sequencing Division at Thermo Fisher Scientific
Recorded November 30, 2021 | Episode 14
Understanding the Clinical and Financial Impact of Unmanaged
Pharmacogenomic Risk
Kristine Ashcraft, Medical Affairs Director, Pharmacogenomics, Invitae
Recorded November 23, 2021 | Episode 13
Precision Medicine for Inpatient Children
Stephen F. Kingsmore, MD, DSc, President and CEO of Rady Children's Institute for Genomic Medicine
Recorded November 16, 2021 | Episode 12
Integrating Personalized Medicine into Healthcare: Advancing From Promise to Reality for More Patients
Elissa Quinn, Precision Medicine Advocacy, Policy & Partnerships at Blueprint Medicines
Recorded November 9, 2021 | Episode 11
The Impact of Artificial Intelligence in Precision Medicine
John Quackenbush, PhD, Professor of Computational Biology and Bioinformatics, Harvard
Chair of the Department of Biostatistics, Harvard T.H. Chan School of Public Health
Recorded October 26, 2021 | Episode 10
The Intersection of Population Health and Precision Medicine: Joining Forces to Improve Public Health Using Targeted Interventions
David Nash, MD, MBA
Founding Dean Emeritus
Dr. Raymond C. & Doris N. Grandon Professor of Health Policy at Jefferson College of Population Health
Recorded October 12, 2021 | Episode 9
Regulatory and Reimbursement Considerations for Precision Medicine
Emily Johnson, Member, McDonald Hopkins
Courtney Tito, Member, McDonald Hopkins
Recorded October 5, 2021 | Episode 8
So, You Want to Bill for NGS Testing? 5 Steps to Avoid Potential Pitfalls
Ann Lambrix
Vice President of RCM Consulting
Vachette Pathology
Recorded September 28, 2021 | Episode 7
Precision Oncology in Community Practice: An Evolving Landscape
Pranil Chandra, DO, FCAP, FASCP
Chief Medical Officer, Vice President, Genomic and Molecular Pathology, PathGroup
Advisor, Precision Medicine Institute
Recorded September 21, 2021 | Episode 6
Molecular Tumor Boards to Help Solve the Precision Medicine ‘Final Mile’ Problem
Howard McLeod, PharmD
Medical Director, Precision Medicine
Geriatric Oncology Consortium
Recorded September 14, 2021 | Episode 5
Precision Medicine: Beyond Science - Why's and How's
Sam Terese
CEO & President
Alverno Laboratories
Recorded September 9, 2021 | Episode 4
The Convergence of Pathology, AI and Drug Development and the Rise of Digital Precision Medicine
Jason Hipp, MD, PhD
Chair, Division of Computational Pathology & AI, Laboratory Medicine & Pathology, Mayo Clinic
Director, Digital Innovation, Mayo Clinic Labs
Recorded August 31, 2021 | Episode 3
The Value of Precision Medicine: Shaping the Future of Healthcare
Julie Ramage
Director of Precision Medicine Quality Initiatives and Partnerships
AstraZeneca Pharmaceuticals
Recorded August 24, 2021 | Episode 2
Pharmacogenomics to Pharmaco-omics
Richard Weinshilboum, MD
Professor of Pharmacology and Medicine and Dasburg Professor of Cancer Genomics Research
Mayo Clinic
Recorded August 17, 2021 | Episode 1
Supporting Precision Oncology with Precision Pathology: The Promise and Challenges of a New Paradigm in Medicine
Anthony Magliocco, MD
Founder & CEO
Protean BioDiagnostics